|
2-ethylbutyl (2S)-2-{[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]amino}propanoate |
|---|---|
| Trade Name | |
| Orphan Indication | Ebola |
| EU Market Approval | EU |
| EU Designation Date | 2016-02-17 00:00:00 |
| Sponsor | Gilead Sciences International Ltd. |
